ECLIPSE 3
Expired
This course is expired
| Welcome & Introduction - Dr. Paul Lacante (BMS Medical Director) |
| Mode of Action video dual IO |
| Dual IO: experience in MESOTHELIOMA - case study (20') plus Q&A (5') - Prof. Dr. Paul Baas |
| Dual IO: experience in NSCLC - case study (20') plus Q&A (5') - Prof. Dr. Luis Paz-Ares |
| Meet the Expert: Panel discussion |
| Meeting close |
ONC-BE-2100170
ONC-BE-2100170
S. Peters et al.; Annals of Oncology 2022 (https://doi.org/10.1016/j.annonc.2022.01.074) manuscript published since webinar dd 10Nov2021.
ONC-BE-2100170
Reck et al.; ESMO open 2021 (https://doi.org/10.1016/j.esmoop.2021.100273) manuscript published since webinar dd 10Nov2021.
ONC-BE-2100170
Experts
Prof. Dr. Paul Baas
Thoracic Oncologist (MD, PhD), The Netherlands Cancer Institute, Amsterdam, The Netherlands
Prof. Dr. Luis Paz- Ares
Thoracic Oncologist (MD, PhD), Hospital Universitario de Madrid, Spain
ONC-BE-2100170
ONC-BE-2100170
ONC-BE-2100170
S. Peters et al.; Annals of Oncology 2022 (https://doi.org/10.1016/j.annonc.2022.01.074) manuscript published since webinar dd 10Nov2021.
ONC-BE-2100170
Reck et al.; ESMO open 2021 (https://doi.org/10.1016/j.esmoop.2021.100273) manuscript published since webinar dd 10Nov2021.
ONC-BE-2100170